Reinfection of SARS CoV-2 in patients with relapse of symptoms after clinical recovery: A Case Series

Main Article Content

Tatikonda Chandramouli
Shakti Bedanta Mishra
Arun Rath

Abstract

Background: It has been more than a year, and still, we are battling with a novel
coronavirus (SARS-COV-2). Initially, the interim guidelines by the World health organization (WHO) stated that infection ranges from asymptomatic to critical life-threatening pneumonia with the symptomatology of fever, cough and breathing difficulty.


Objectives: To observe the reinfection of SARS CoV-2 in patients with relapse of symptoms after clinical recovery.


Materials and methods: Three cases were observed during the isolation period. Reverse transcription polymerase chain reaction (RT-PCR) and severity of similar symptoms in the fourth week from the onset was monitored.


Results: All the three patients had health care exposure, and which pointed us towards health care associated reinfection could be a possible cause of step-up in the symptom severity.


Conclusion: Reinfection by SARS CoV-2 can be considered in patients with relapse of symptoms after clinical recovery after natural infections.

Article Details

How to Cite
Chandramouli, . T., Mishra, S. B., & Rath, A. . (2022). Reinfection of SARS CoV-2 in patients with relapse of symptoms after clinical recovery: A Case Series. Journal of Associated Medical Sciences, 55(3), 105–108. Retrieved from https://he01.tci-thaijo.org/index.php/bulletinAMS/article/view/255037
Section
Research Articles

References

Mehta Y, Chaudhry D, Abraham OC, Chacko J, Divatia J, Jagiasi B, et al. Critical Care for COVID-19 Affected Patients: Position Statement of the Indian Society of Critical Care Medicine. Indian J Crit Care Med. 2020; 24(4): 222-41. doi: 10.5005/jp-journals-10071-23395.

Adukia SA, Ruhatiya RS, Maheshwarappa HM, Manjunath RB, Jain GN. Extrapulmonary Features of COVID-19: A Concise Review. Indian J Crit Care Med. 2020; 24(7): 575-80. doi: 10.5005/jp-journals-10071-23476.

COVID-19 Treatment Guidelines Panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. 2020 [cited 2022 January 26]. Available from:https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf.

RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med.2021; 384(8), 693-704. https://doi.org/10.1056/NEJMoa2021436.

Grasselli G, Tonetti T, Protti A, Langer T, Girardis M, Bellani G, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020; 8(12): 1201-8. doi: 10.1016/S2213-2600(20)30370-2.

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8): 782-93. doi: 10.1001/jama.2020.12839.

Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020; 20(8): 911-9. doi: 10.1016/S1473-3099(20)30287-5.

World Health Organization. Transmission of SARS-CoV-2: implications for infection prevention precautions: scientific brief. 2020 [Cited 2022 January 26]. Available from: https://apps.who.int/iris/handle/10665/333114.

Hansen CH, Michlmayr D, Gubbels SM, Mølbak K, Ethelberg S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet. 2021; 397(10280): 1204-12. doi: 10.1016/S0140-6736(21)00575-4.

Boyton RJ, Altmann DM. Risk of SARS-CoV-2 reinfection after natural infection. Lancet. 2021; 397(10280): 1161-3. doi: 10.1016/S0140-6736(21)00662-0.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061-9. doi: 10.1001/jama.2020.1585.

Kuanar A, Kabi SK, Satapathy S, Mishra S, Bhuyan R, Kar D. Corona Virus-A review concerns about the present scenario. Ann. Romanian Soc. Cell Biol. 2021; 25(2): 1301-15.

Taribagil P, Creer D, Tahir H. 'Long COVID' syndrome. BMJ Case Rep. 2021; 14(4): e241485. doi: 10.1136/bcr-2020-241485.